FCMI
Foresite Capital Management IV Portfolio holdings
AUM
$124M
1-Year Return
24.36%
This Quarter Return
-11.43%
1 Year Return
-24.36%
3 Year Return
+1.86%
5 Year Return
+16.17%
10 Year Return
–
AUM
$193M
AUM Growth
-$41.4M
(-18%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KNTE
1
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $60.4M | 31.36% |
9,671,643
| – | – |
|
2
Pharvaris
PHVS
$1.51B
| $26.2M | 13.57% |
3,246,926
| – | – |
|
3
Lyell Immunopharma
LYEL
$256M
| $23.6M | 12.25% |
500,000
| – | – |
|
4
Aclaris Therapeutics
ACRS
$230M
| $22.7M | 11.79% |
2,808,034
| – | – |
|
5
Kura Oncology
KURA
$691M
| $22.6M | 11.74% |
1,849,947
| – | – |
|
6
Syndax Pharmaceuticals
SNDX
$1.36B
| $18.5M | 9.59% |
875,000
| – | – |
|
|
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
| $15.6M | 8.09% |
1,787,094
| – | – |
|
8
Quantum-Si Incorporated
QSI
$231M
| $3.12M | 1.62% |
1,771,249
| – | – |
|